Additionally, other TFs that we nominated in this study as candidate DLAM TFs (MAF, MEF2C, and SPI1) were also nominated as candidate AD risk genes in genome-wide association studies (GWAS)33,71,72. This evidence concerns the gene MEF2C and Alzheimer disease.